| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | - | 0 | 0 | 0 | 0 | 8.818 | 0 | - |
| Total Income - EUR | 0 | 0 | - | 0 | 0 | 136 | 50 | 8.843 | 0 | - |
| Total Expenses - EUR | 1.041 | 1.087 | - | 0 | 2.773 | 2.502 | 3.315 | 1.309 | 3.128 | - |
| Gross Profit/Loss - EUR | -1.041 | -1.087 | - | 0 | -2.773 | -2.366 | -3.265 | 7.534 | -3.128 | - |
| Net Profit/Loss - EUR | -1.041 | -1.087 | - | 0 | -2.773 | -2.366 | -3.265 | 7.269 | -3.128 | - |
| Employees | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Minovici Medical Development Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 0 | 0 | 8.990 | 8.424 | 8.083 | 7.692 | - |
| Current Assets | 537 | 749 | - | 888 | 1.347 | 5.511 | 4.059 | 12.945 | 2.336 | - |
| Inventories | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 537 | 749 | - | 888 | 1.347 | 3.478 | 3.619 | 12.600 | 2.100 | - |
| Cash | 0 | 0 | - | 0 | 0 | 2.033 | 440 | 346 | 236 | - |
| Shareholders Funds | -18.475 | -19.374 | - | -20.059 | -22.444 | -24.384 | -27.109 | -19.924 | -22.992 | - |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 19.012 | 20.123 | - | 20.947 | 23.791 | 38.885 | 39.592 | 40.952 | 33.020 | - |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5829 - 5829" | |||||||||
| CAEN Financial Year |
5829
|
|||||||||
Comments - Minovici Medical Development Srl